SSA
AIFF

Schonfeld Strategic Advisors’s Firefly Neuroscience AIFF Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-177,185
Closed -$386K – 3096
2026
Q1 		$386K Buy
+177,185
New +$221K ﹤0.01% 1484

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM

Schonfeld Strategic Advisors's AIFF Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Firefly Neuroscience (AIFF) in Q2 2026, closing a stake of 177,185 shares — an estimated $386K sold.

Schonfeld Strategic Advisors first reported a position in AIFF in Q1 2026 and held it in 1 quarter. The position peaked at $386K in Q1 2026. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Firefly Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 177,185 Firefly Neuroscience shares in Q2 2026, an estimated $386K.
  • Schonfeld Strategic Advisors first reported a position in Firefly Neuroscience in Q1 2026 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Firefly Neuroscience position peaked at $386K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.